Table 6.
Cox regression analysis evaluating the association of drugs with mortality among patients with mild and moderate disease.
| Variable | Univariate |
Multivariate |
||
|---|---|---|---|---|
| HR | p-value | Adjusted HR | p-value | |
| Sex (male) | 1.07 (0.57–2.02) | 0.826 | 1.00 (0.52–1.92) | 1.000 |
| Age (>60 years) | 3.94 (2.10–7.39) | <0.001∗ | 3.17 (1.63–6.17) | 0.001∗ |
| Comorbidity present (any) | 2.91 (1.38–6.13) | 0.005∗ | 2.41 (1.12–5.18) | 0.024∗ |
| Drugs | ||||
| Steroids | 1.98 (1.04–3.78) | 0.038∗ | 2.81 (1.09–7.25) | 0.033∗ |
| Antibiotics | 2.03 (1.04–3.95) | 0.037∗ | 1.23 (0.59–2.59) | 0.579 |
| Anticoagulants | 0.93 (0.49–1.77) | 0.834 | 0.60 (0.23–1.55) | 0.291 |
| Favipiravir | 0.29 (0.14–0.60) | 0.001∗ | 0.24 (0.11–0.54) | 0.001∗ |
| Remdesivir | 2.32 (1.06–5.04) | 0.034∗ | 0.89 (0.31–2.53) | 0.827 |
COVID-19, coronavirus disease 2019; HR, hazard ratio; ∗, statistically significant (p-value <0.05).